The Tape
Markets, money, and the policy that moves them.
Sunday, November 8, 2026 · UTC
The Markets

Rosen Law Firm opens ARS Pharmaceuticals class action probe and continues TruBridge investigation

Shareholders of ARS Pharmaceuticals face an October 5 deadline to join a lawsuit, while TruBridge shareholders remain part of an ongoing inquiry.

Marcus Vance
Markets Reporter
Share on X
Stands on 2 placed sources from 2 publishers.
As of 2026-09-05 02:37 UTC. Market figures are as the cited sources reported them at that time and may have moved since. This is news, not investment advice.
Rosen Law Firm is notifying purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026 of an October 5, 2026 lead plaintiff deadline [1].